[Remote] Director Upstream Product Marketing PSMA Late Stage

Note: The job is a remote job and is open to candidates in USA. Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with a mission to deliver on the promise of precision medicine through targeted radiation. The Director, Product Marketing – Upstream Late-Stage PSMA is responsible for shaping the commercial vision and lifecycle strategy for Telix’s late-stage PSMA imaging portfolio, ensuring optimal product positioning and alignment across teams.ResponsibilitiesLead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programsServe as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. Working closely with the Global Commercial PSMA teamBuild and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisionsPartner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation prioritiesOwn the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modelingCollaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptionsAnticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisionsConvert complex commercial analyses into clear, strategic recommendations for regional leadership teamsAct as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readinessLead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activitiesOversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworksEnsure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regionsOversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advancesProvide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plansMonitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoptionLead high-impact strategic initiatives such as lifecycle indication launches, expansion projects, and multi-regional alignment activitiesDrive execution excellence by setting timelines, governance structures, and communication standards for cross-functional teamsPresent strategic updates, insights, and recommendations to executive leadership and participate in PMC and portfolio governance forumsSkillsBachelor's degree in Marketing, Business, or Life Sciences; MBA or advanced degree strongly preferred8–12+ years of experience in pharmaceutical, biotech, molecular imaging, medical device or diagnostics marketing, ideally in oncology or urologyProven experience leading upstream product strategy, lifecycle management, or commercial planning for late-stage assetsStrong ability to synthesize scientific, clinical, communicate commercial insights into strategic decision-makingDemonstrated success influencing cross-functional teams in complex, matrixed environmentsStrong financial and analytical acumen, with experience developing sophisticated forecasts and investment casesExceptional communication, executive presentation, and stakeholder leadership skillsAdvanced project leadership and organizational capabilitiesBenefitsCompetitive salariesAnnual performance-based bonusesAn equity-based incentive programGenerous vacationPaid wellness daysSupport for learning and developmentHybrid and remote employees located all around the worldCompany OverviewTelix is a global biopharmaceutical company focused on the development and commercialization of radiopharmaceuticals to address significant unmet medical need in oncology and rare diseases. It was founded in 2015, and is headquartered in Melbourne, Victoria, AUS, with a workforce of 1001-5000 employees. Its website is http://www.telixpharma.com.